UTHR - ユナイテッド・セラピュ―ティクス (United Therapeutics Corporation)

UTHRのニュース

   United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q1 2022 Results - Earnings Call Transcript  2022/05/04 16:06:05 Seeking Alpha
United Therapeutics Corporation (NASDAQ:NASDAQ:UTHR) Q1 2022 Results Conference Call May 04, 2022 09:00 AM ET Company Participants Dewey Steadman - Head, IR Martine Rothblatt - Chairperson,…
   United Therapeutics Corporation Reports First Quarter 2022 Financial Results - Stocks News Feed  2022/05/04 13:00:00 Stocks News Feed
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended March 31, 2022. Total revenue in the first quarter of 2022 grew 22% year-over-year to $461.9 million, compared to $379.1 million in the first quarter of 2021. “The hard… Read More »United Therapeutics Corporation Reports First Quarter 2022 Financial Results
   Recap: United Therapeutics Q1 Earnings  2022/05/04 11:47:33 Benzinga
United Therapeutics (NASDAQ: UTHR ) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here''s what investors need to know about the announcement. Earnings United Therapeutics beat estimated earnings by 50.6%, reporting an EPS of $5.03 versus … Full story available on Benzinga.com
   United Therapeutics GAAP EPS of $5.03 beats by $1.96, revenue of $461.9M beats by $41.88M (NASDAQ:UTHR)  2022/05/04 10:03:19 Seeking Alpha
United Therapeutics press release (UTHR): Q1 GAAP EPS of $5.03 beats by $1.96.Revenue of $461.9M (+21.8% Y/Y) beats by $41.88M.“With this positive momentum, we continue to work…
   United Therapeutics Corporation Reports First Quarter 2022 Financial Results  2022/05/04 10:00:00 Business Wire
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended March 31, 20
   Builders and VCs explore the impact of air mobility on urban planning at TC Sessions: Mobility 2022 – TechCrunch  2022/03/22 15:00:49 TechCrunch
Over the past decade, some of the biggest names in the tech, VC, automotive and aerospace industries have poured millions of dollars into developing electric vertical take-off and landing (eVTOL) aircraft. And that investment trend shows no sign of slowing any time soon. Just some of these investors include Google co-founder Larry Page, United Therapeutics […]
   Builders and VCs explore the impact of air mobility on urban planning at TC Sessions: Mobility 2022  2022/03/22 15:00:49 TechCrunch
Over the past decade, some of the biggest names in the tech, VC, automotive and aerospace industries have poured millions of dollars into developing electric vertical take-off and landing (eVTOL) aircraft. And that investment trend shows no sign of slowing any time soon. Just some of these investors include Google co-founder Larry Page, United Therapeutics […]
   Md. man who received pig heart developed by United Therapeutics dies  2022/03/10 13:26:22 Business Journals
David Bennett, 57, lived for two months after receiving the experimental organ transplant.
   United Therapeutics slips amid reports person in groundbreaking heart transplant died after two months  2022/03/09 16:13:21 Seeking Alpha
The first person to receive a heart transplant from a pig has died on Tuesday after two months from the landmark surgery at the University of Maryland Medical Center, the hospital…
   Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease  2022/02/28 11:00:00 EFE News Service
Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease | Comunicados | Edición USA | Agencia EFE
   United Therapeutics Corp (UTHR) EVP & General Counsel Paul A Mahon Sold $1.3 million of Shares  2021/09/03 00:15:03 GuruFocus
Related Stocks: UTHR ,
   Jefferies says investors should buy these 23 stocks to outperform in an increasingly nervous market and because they have 135% upside on average  2021/08/22 09:00:00 Business Insider
Summary List Placement The stock market is at all-time highs and COVID-19 cases are ticking higher, and that might be bringing back some uncomfortable memories of early 2020 for investors. Jefferies'' equity research unit says the combination of rising COVID cases, geopolitical issues, and the Fed''s position on monetary policy might make for a tough investing environment, but advises against heading for the exits. "Economic data releases remain generally encouraging and the lack of stepped-up lockdowns in the US suggest that the progression of the recovery has slowed not stalled," the firm wrote. "This change of pace provides an opening for outperformance based on single stock selection." The firm says it sees three broad categories of winners that could prove to be severely undervalued if they are able to achieve their aims and if economic progress continues. Those categories are companies with specific catalysts, companies benefiting from structural growth, and those that should outperform because they''re so highly levered to the recovery. "Companies with more leverage to the economic cycle have seen share prices largely tumble, despite generally solid 2Q results and positive revisions," said Jefferies. "Consequently, many of these companies now appear substantially cheaper than earlier in 2021, when stock prices were loftier and Street forecasts much lower." Others are struggling for more individualized reasons, although some of those are also linked to the effects of the pandemic.
   UNITED THERAPEUTICS Corp (UTHR): Price Up $2.65 (1.3)% Over Past Day, Up $2.03 (0.99)% Over Past Hour  2021/08/18 15:18:42 ETF Daily News
Regarding the trend, note that the strongest trend exists on the 50 hour timeframe. The post UNITED THERAPEUTICS Corp (UTHR): Price Up $2.65 (1.3)% Over Past Day, Up $2.03 (0.99)% Over Past Hour appeared first on ETF Daily News .
   MannKind and United Therapeutics ink supply agreement for Tyvaso and BluHale  2021/08/16 11:26:10 Seeking Alpha
   Exosome Therapeutic Market Astonishing Growth with Top Influencing Key Players like evox THERAPEUTICS, EXOCOBIO, Exopharm, AEGLE Therapeutics, United Therapeutics Corporation, Codiak BioSciences  2021/08/06 18:09:54 OpenPR
An international Exosome Therapeutic Market report is the best source that gives CAGR values with variations during the forecast period of 2021-2028 for the market. The study encompasses market drivers and restraints by using SWOT analysis, along with their impact

calendar